Rousselot’s SiMoGel gelatin technology for gummy supplements gains U.S. patent
SiMoGel eliminates the need for starch-based gummy production.
Rousselot (Irving, TX), a brand of Darling Ingredients, announced a new U.S. patent (No. 11,490,634) for intellectual property around the company’s SiMoGel gelatin technology. SiMoGel is said to eliminate the need for starch-based gummy production.
“SiMoGel allows for the production of nutraceutical gummies using silicon or metal molds, which are easily cleanable and eliminate dust during production, unlike traditional starch trays,” the company explained in a press release. “SiMoGel also significantly reduces setting time to less than 30 minutes, compared to 24 hours for conventional starch-based production.”
SiMoGel also gained a patent from the European Patent Office in November 2021 covering all major European countries, the company said.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
